Stay updated on Ligelizumab in CSU Adolescents & Adults Clinical Trial
Sign up to get notified when there's something new on the Ligelizumab in CSU Adolescents & Adults Clinical Trial page.

Latest updates to the Ligelizumab in CSU Adolescents & Adults Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRecruitment status updated to not recruiting participants, and new guidance sections added to help readers navigate and understand the study record; a heading refinement and a revision note accompany the update.SummaryDifference0.2%

- Check16 days agoChange DetectedThe Revision line was updated from v3.5.4 to v3.5.5, reflecting a minor version update to the page's metadata.SummaryDifference0.0%

- Check38 days agoChange DetectedThe site's revision tag was updated from v3.5.3 to v3.5.4, indicating a deployment of software updates to the ClinicalTrials.gov interface. This is a technical version change and does not modify the study data or content displayed on the page.SummaryDifference0.0%

- Check52 days agoChange DetectedThe Taiwan site location in the study locations was updated from Taoyuan District to Taoyuan, Taiwan, 33305, indicating a shift to the city-level designation while preserving the same postal code.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page footer revision/version label has been updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision v3.5.0 was removed and revision v3.5.2 was added.SummaryDifference0.0%

Stay in the know with updates to Ligelizumab in CSU Adolescents & Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ligelizumab in CSU Adolescents & Adults Clinical Trial page.